The diGItal Project - Advancing Digital Patient Communication Together
Digital Package Leaflets in the Context of the EU Pharmaceutical Package
With the agreement reached between the Council of the EU and the European Parliament on the EU Pharmaceutical Package, the European Union is introducing new requirements aimed at creating a fairer and more competitive pharmaceutical sector. A key element of this reform is the mandatory provision of electronic Product Information (ePI) for pharmaceuticals. Implementing these requirements will require pharmaceutical companies to make both regulatory and technical adjustments while accelerating the adoption of digital solutions.
The diGItal project, an initiative of the German pharmaceutical industry associations, aims to prepare for the future legal implementation of these requirements in Germany. Drawing on its extensive expertise in ePI, Rote Liste has been involved in this pioneering project from the very beginning.
Benefits of the diGital Project
Preparing for Future Regulatory Requirements
Gaining Practical Experiences
Companies can build and test the necessary infrastructure and prepare for the process changes. that structured digital package leaflet management will require.
From PDF Documents to Structured Data
Strengthening Digital Competitiveness

The diGItal Project
The diGItal project is a joint initiative of Germany’s four pharmaceutical industry associations: BPI, PharmaDeutschland, Pro Generika, and vfa. Its objective is to establish a trusted source for digital Patient Information Leaflets (PILs). PharmaProtect Solutions, owned by all four associations, is the responsible project owner. Today, practical use cases are already being tested to demonstrate how digital package leaflets can be provided and used. Examples include integration into health insurance apps and a hospital pilot project that enables the replacement of printed package leaflets.
Through the diGItal project, Germany is preparing early for future legal requirements by establishing the necessary technical and organizational framework. At the same time, valuable real-world insights are being generated to help shape future regulatory developments.

The Role of Rote Liste
Rote Liste has supported the diGItal project from the outset as an established partner for structured medicinal product information. It actively assists pharmaceutical companies in converting their package leaflets into a digital, structured format while contributing its technological infrastructure and extensive regulatory expertise.
The technological foundation is GI 4.0®, a platform jointly developed by industry stakeholders, regulatory authorities, and patient representatives. GI 4.0 provides a comprehensive repository of structured package leaflet information and supports the practical implementation of digital patient information solutions.
Participation in the diGItal Project
Pharmaceutical companies can register via the diGItal project website to participate and gain early experience with the digital provision of package leaflets.
Stay informed
Subscribe to our newsletter for pharmaceutical companies to receive regular updates from Rote Liste.